Followers | 12 |
Posts | 1060 |
Boards Moderated | 0 |
Alias Born | 06/29/2017 |
Wednesday, September 02, 2020 10:49:15 PM
The study reveals key finding about specific IgM, IgG1, and IgA1 antibody not only present in plasma or serum of almost all analyzed COVID-19 convalescent study subjects, most significantly is that these antibodies were also detected at exceptionally early stages of the infection (i.e., 7-8 days after disease onset).
This may set a new criteria and create great opportunity for serological tests used in screening convalescent plasma for the emergency therapeutic application critical for treating severe COVID-19 patients.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM